9 July 2025
Sarcoma and Bone Cancer Awareness Month


July is Sarcoma and Bone Cancer Awareness Month, and various global activities are aiming to highlight and increase the awareness of sarcoma and bone cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of sarcoma and bone cancer, which were published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant papers can be seen below:

Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings
by Jun-Ho Kim and Seul Ki Lee
Cancers 2023, 15(6), 1703; https://doi.org/10.3390/cancers15061703
Available online: https://www.mdpi.com/2072-6694/15/6/1703

Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin
by
Valentina Fausti, Alessandro De Vita, Silvia Vanni, Virginia Ghini, Lorena Gurrieri, Nada Riva, Roberto Casadei, Marco Maraldi, Giorgio Ercolani, Davide Cavaliere et al.
Cancers 2023, 15(4), 1080; https://doi.org/10.3390/cancers15041080   
Available online: https://www.mdpi.com/2072-6694/15/4/1080

Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis
by
Bikesh K. Nirala, Taku Yamamichi, D. Isabel Petrescu, Tasnuva N. Shafin and Jason T. Yustein
Cancers 2023, 15(20), 5108; https://doi.org/10.3390/cancers15205108  
Available online: https://www.mdpi.com/2072-6694/15/20/5108

Osteosarcoma in Pediatric and Adult Populations: Are Adults Just Big Kids?
by
Caleb Kim, Lara E. Davis, Catherine M. Albert, Brian Samuels, Jesse L. Roberts and Michael J. Wagner
Cancers 2023, 15(20), 5044; https://doi.org/10.3390/cancers15205044
Available online: https://www.mdpi.com/2072-6694/15/20/5044

SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma
by
Erlinda Maria Gordon, Sant P. Chawla, Walter Andree Tellez, Elan Younesi, Sonu Thomas, Victoria S. Chua-Alcala, Hripsime Chomoyan, Chrysler Valencia, Don Arlen Brigham, Ania Moradkhani et al.
Cancers 2023, 15(3), 906; https://doi.org/10.3390/cancers15030906  
Available online: https://www.mdpi.com/2072-6694/15/3/906

Application of Machine Learning for Differentiating Bone Malignancy on Imaging: A Systematic Review
by
Wilson Ong, Lei Zhu, Yi Liang Tan, Ee Chin Teo, Jiong Hao Tan, Naresh Kumar, Balamurugan A. Vellayappan, Beng Chin Ooi, Swee Tian Quek, Andrew Makmur et al.
Cancers 2023, 15(6), 1837; https://doi.org/10.3390/cancers15061837  
Available online: https://www.mdpi.com/2072-6694/15/6/1837

Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group
by
Bettina Jansko-Gadermeir, Michael Leisch, Franz J. Gassner, Nadja Zaborsky, Thomas Dillinger, Sonja Hutter, Angela Risch, Thomas Melchardt, Alexander Egle, Manuel Drost et al.
Cancers 2023, 15(8), 2305; https://doi.org/10.3390/cancers15082305
Available online: https://www.mdpi.com/2072-6694/15/8/2305

Endogenous Extracellular Matrix Regulates the Response of Osteosarcoma 3D Spheroids to Doxorubicin
by
Margherita Cortini, Francesca Macchi, Francesca Reggiani, Emanuele Vitale, Maria Veronica Lipreri, Francesca Perut, Alessia Ciarrocchi, Nicola Baldini and Sofia Avnet
Cancers 2023, 15(4), 1221; https://doi.org/10.3390/cancers15041221  
Available online: https://www.mdpi.com/2072-6694/15/4/1221

Deep Learning Approaches to Osteosarcoma Diagnosis and Classification: A Comparative Methodological Approach
by
Ioannis A. Vezakis, George I. Lambrou and George K. Matsopoulos
Cancers 2023, 15(8), 2290; https://doi.org/10.3390/cancers15082290
Available online: https://www.mdpi.com/2072-6694/15/8/2290

Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design
by
Bradford S. Hoppe, Ivy A. Petersen, Benjamin K. Wilke, Todd A. DeWees, Reiko Imai, Eugen B. Hug, Maria Rosaria Fiore, Jürgen Debus, Piero Fossati, Shigeru Yamada et al.
Cancers 2023, 15(6), 1660; https://doi.org/10.3390/cancers15061660
Available online: https://www.mdpi.com/2072-6694/15/6/1660

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

Back to TopTop